1 | MSV000095578 | Development and qualification of a dendritic cell internalization assay contributing to the immunogenicity risk evaluation of biotherapeutics | false |  |
2 | MSV000095695 | Internalization of therapeutic antibodies into Dendritic cells as a risk factor for immunogenicity | false |  |
3 | MSV000085375 | Enabling Routine MHC-II Associated Peptide ProteomicS (MAPPs) for Risk Assessment of Drug-Induced Immunogenicity | false |  |
4 | MSV000092747 | Expanding the MAPPs assay to accommodate MHC-II pan re-ceptors for improved predictability of potential T cell epitopes | false |  |